These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5296082)

  • 41. [Editorial: Antinuclear antibodies in SLE].
    Levo Y; Pick AI
    Harefuah; 1973 Sep; 85(6):282-3. PubMed ID: 4544152
    [No Abstract]   [Full Text] [Related]  

  • 42. Penetration of the antinuclear factor (A.N.F.) into chicken red cells.
    Feltkamp TE; Kruyff K
    Vox Sang; 1963; 8(3):302-7. PubMed ID: 4959167
    [No Abstract]   [Full Text] [Related]  

  • 43. Antinuclear antibodies in systemic lupus erythematosus.
    HOLMAN H; ROBBINS W
    Arthritis Rheum; 1959 Oct; 2():468-71. PubMed ID: 14402747
    [No Abstract]   [Full Text] [Related]  

  • 44. Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities.
    Willems P; De Langhe E; Westhovens R; Vanderschueren S; Blockmans D; Bossuyt X
    Ann Rheum Dis; 2019 Aug; 78(8):e76. PubMed ID: 29936439
    [No Abstract]   [Full Text] [Related]  

  • 45. [THE ANTI-NUCLEAR ANTIBODIES OF DISSEMINATED LUPUS ERYTHEMATOSUS].
    SELIGMANN M
    Brux Med; 1965 Feb; 45():169-88. PubMed ID: 14300061
    [No Abstract]   [Full Text] [Related]  

  • 46. [ON THE ANTINUCLEAR FACTOR IN COLLAGEN DISEASES, WITH SPECIAL REFERENCE TO ACUTE LUPUS ERYTHEMATOSUS].
    MINAMI K; KODA H; TOGEGAWA S
    Fukuoka Igaku Zasshi; 1964 Mar; 55():167-73. PubMed ID: 14165106
    [No Abstract]   [Full Text] [Related]  

  • 47. Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multicentre study.
    Pregnolato F; Borghi MO; Meroni PL;
    Ann Rheum Dis; 2019 Jun; 78(6):e50. PubMed ID: 29695499
    [No Abstract]   [Full Text] [Related]  

  • 48. Quantitative observations on antinuclear factors in systemic lupus erythematosus.
    MANDEMA E; POLLAK VE; KARK RM; REZAIAN J
    J Lab Clin Med; 1961 Sep; 58():337-52. PubMed ID: 13766082
    [No Abstract]   [Full Text] [Related]  

  • 49. Antinuclear antibodies in cryoglobulinaemic diseases.
    Mazzei D; Cattaneo C; Novi C; Simonati V
    Lancet; 1969 Jan; 1(7585):104-5. PubMed ID: 4177992
    [No Abstract]   [Full Text] [Related]  

  • 50. The nuclear compartment of living cells is not an absolute immunologically sequestered site: evidence for spontaneous intranuclear entry of lupus autoantibodies to living cells.
    Golan TD
    Leukemia; 1997 Jan; 11(1):6-9. PubMed ID: 9001410
    [No Abstract]   [Full Text] [Related]  

  • 51. Anti-nuclear antibodies in systemic lupus erythematosus and in other diseases.
    LIMA AO; FRAGA C; SEABRA O
    Hospital (Rio J); 1961 Nov; 60():569-80. PubMed ID: 14465301
    [No Abstract]   [Full Text] [Related]  

  • 52. [Semi-quantitative investigation on the presence of antinuclear factors in patients and relatives of patients with disseminated lupus erythematosus].
    POLLAK VE; KARK RM
    Ned Tijdschr Geneeskd; 1962 Apr; 106():755-8. PubMed ID: 14487626
    [No Abstract]   [Full Text] [Related]  

  • 53. [Recent immunological advances in systemic lupus erythematosus].
    Galanaud P; Delfraissy JF; Segond P; Dormont J
    Rev Med Interne; 1980; 1(2):147-51. PubMed ID: 6973179
    [No Abstract]   [Full Text] [Related]  

  • 54. Localization of antinuclear factors from lupus erythematosus sera in tissue culture.
    RAPP F
    J Immunol; 1962 Jun; 88():732-40. PubMed ID: 14490373
    [No Abstract]   [Full Text] [Related]  

  • 55. Two types of lupus erythematosus cell factor, shown by induced L.E. cell phenomenon in man.
    BENCZE G; KOVACS J; CSERHATI J
    Br Med J; 1959 Oct; 2(5156):864. PubMed ID: 13798735
    [No Abstract]   [Full Text] [Related]  

  • 56. Structure--function relationships of anti-DNA antibodies.
    Kalsi JK; Martin AC; Isenberg DA
    Lupus; 1995 Aug; 4(4):245-8. PubMed ID: 8528217
    [No Abstract]   [Full Text] [Related]  

  • 57. Induction by isoniazid and hydrallazine of antinuclear factors in mice.
    Cannat A; Seligmann M
    Clin Exp Immunol; 1968 Jan; 3(1):99-105. PubMed ID: 5300375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease.
    Piga M; Floris A; Mathieu A; Cauli A
    Rheumatology (Oxford); 2017 Nov; 56(11):2038-2039. PubMed ID: 28968887
    [No Abstract]   [Full Text] [Related]  

  • 59. Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease: reply.
    de Leeuw K; Bungener L; Roozendaal C; Bootsma H; Stegeman CA
    Rheumatology (Oxford); 2017 Nov; 56(11):2039-2040. PubMed ID: 28968693
    [No Abstract]   [Full Text] [Related]  

  • 60. Significance of antinuclear antibodies.
    Mitchell SR
    J Pediatr; 1990 Sep; 117(3):513. PubMed ID: 2391615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.